Axogen, Inc. AXGN

Latest FY: 2025 Healthcare Medical Devices
Market Price $48.76
Market Cap $2.56B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑20.2% YoY
$225.21M
3-Yr CAGR: 17.6%
Net Income ↓-57.6% YoY
-$15.70M
Net Margin: -7.0%
Free Cash Flow ↓-304.5% YoY
-$2.93M
FCF Yield: -0.11%
EPS (Diluted) ↓-47.8% YoY
$-0.34
Basic: $-0.34
Return on Equity Efficiency
-12.2%
ROA: -247.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AXGN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $41.1M $34.6M $-14.4M $-0.47 $-11.2M $-12.2M
FY 2017 $60.4M +47.0% $51.1M $-10.4M +27.5% $-0.31 +34.0% $-9.2M $-10.3M +15.2%
FY 2018 $83.9M +38.9% $71.0M $-22.4M -114.4% $-0.60 -93.5% $-17.9M $-24.1M -133.4%
FY 2019 $106.7M +27.1% $89.4M $-29.1M -30.1% $-0.74 -23.3% $-19.9M $-24.5M -1.6%
FY 2020 $112.3M +5.2% $90.7M $-23.8M +18.4% $-0.60 +18.9% $-9.6M $-31.5M -28.5%
FY 2021 $127.4M +13.4% $104.4M $-27.0M -13.4% $-0.65 -8.3% $-13.4M $-41.2M -30.7%
FY 2022 $138.6M +8.8% $114.4M $-28.9M -7.3% $-0.69 -6.2% $-16.1M $-36.1M +12.3%
FY 2023 $159.0M +14.7% $127.9M $-21.7M +25.0% $-0.51 +26.1% $-5.7M $-19.6M +45.8%
FY 2024 $187.3M +17.8% $142.0M $-10.0M +54.1% $-0.23 +54.9% $4.5M $1.4M +107.3%
FY 2025 $225.2M +20.2% $167.4M $-15.7M -57.6% $-0.34 -47.8% $0.8M $-2.9M -304.5%
$

Valuation

Market Price $48.76
Market Cap $2.56B
Enterprise Value $2.57B
P/E Ratio N/A
P/B Ratio 20.12
FCF Yield -0.11%
Dividend Yield N/A
Shares Outstanding 53,177,800
%

Profitability & Margins

Gross Margin 74.31%
Operating Margin -3.49%
Net Margin -6.97%
Return on Equity (ROE) -12.19%
Return on Assets (ROA) -247.21%
Asset Turnover 35.45x
Revenue 3-Yr CAGR 17.57%
🛡️

Financial Health & Liquidity

Current Ratio 0.27
Cash Ratio 1.51
Debt / Equity 0.394
Debt / Assets 7.991
Cash & Equivalents $35.55M
Total Debt $50.76M
Book Value / Share $2.42
💧

Cash Flow Efficiency

Operating Cash Flow $812.00K
Capital Expenditures (CapEx) $3.75M
Free Cash Flow -$2.93M
OCF / Revenue 0.36%
FCF / Revenue -1.30%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.34
EPS (Basic) $-0.34
Dividends / Share N/A
Book Value / Share $2.42
EPS YoY Growth -47.83%
🏛️

Balance Sheet (FY 2025)

Total Assets $6.35M
Total Liabilities $23.56M
Stockholders' Equity $128.85M
Current Assets $6.35M
Current Liabilities $23.56M